The transferred CTLs pretreated with UA substantially enhanced the IFN‐γ, TNF‐α, IL‐2, and granzyme B‐producing capacity in the tumor, spleen, and lymph node (Figure 1Q; Figure S2H–J, Supporting Information). This evidence concerns the gene TNF and neoplasm.